1st MTX use in 242 Italian pts w/ chronic inflam arthritis (54% RA, 33% PsA, 16% UA). Overall, survival of MTX at 24 months was 60%, (40% @48 mos, 20% @96 mos). MTX survival in RA & PsA equal, but superior to UA (undiff. arthritis) https://t.co/g4pZpVmTnM https://t.co/gcKWriqfhG
Links:
Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthriti…
https://buff.ly/3ZVL9vU
Dec-16-2024
